TEDDY队列研究:6岁前与6岁后诊断1型糖尿病儿童的特征比较
TEDDY研究对8502名遗传高风险儿童从出生随访中位9.9年,328名(3.9%)诊断为1型糖尿病。6岁前诊断者自身抗体出现更早(平均1.5 vs 3.5岁)、进展更快(平均1.9 vs 5.4年),且以胰岛素自身抗体(IAA)为先;6岁后诊断者中IA-2A首现仅见于该组,HLA基因型风险仍显著。
要点
- 6岁前诊断的1型糖尿病起病前多先出现IAA,疾病进展更迅速。
- 6岁后诊断者中,多自身抗体出现后进展与年龄或家族史无关。
- rs1004446(INS)次要等位基因降低两组风险(HR 0.67)。
核心结论
- 早发1型糖尿病更可能以IAA自身抗体为先导,且为侵袭性更强的疾病形式。
- 在年长儿童中,一旦观察到多自身抗体,进展至糖尿病似乎与年龄或家族史无关。
研究设计与样本
- TEDDY队列研究,纳入遗传高风险儿童n=8502,从出生随访中位9.9年。
- 328名(3.9%)诊断为1型糖尿病,采用Cox比例风险模型评估两组预后因素与风险。
主要发现
- 年轻组自身抗体出现更早(平均年龄1.5 vs 3.5岁),IAA早于GADA出现。
- 年轻组进展至糖尿病更快(平均病程1.9 vs 5.4年)。
- 以IA-2A为首现自身抗体者仅见于年长组。
- 年轻组中出生国家相关的糖尿病风险在年长组不再显著;HLA基因型风险在年长组仍显著。
- 多自身抗体阳性儿童中,2岁前后首次血清转换与糖尿病诊断风险降低相关;若首次血清转换在2岁后,风险不随年龄进一步降低。
关键数值与推荐
- rs1004446(INS)次要等位基因在年轻组和年长组均降低风险(HR 0.67)。
- rs2476601(PTPN22)次要等位基因增加风险(HR 2.04和1.72,分别为年轻组和年长组)。
- rs428595(PPIL2)次要等位基因增加风险(HR 2.13和2.10)。
- rs113306148(PLEKHA1)次要等位基因增加风险(HR 2.34和2.21)。
- rs73043122(RNASET2)次要等位基因增加风险(HR 2.31和2.54)。
临床怎么用
- 对遗传高风险幼儿应重视IAA筛查,其早现提示更快速进展风险。
- 年长儿童出现多自身抗体后,进展风险与年龄或家族史关联不明显。
- 遗传风险评分可参考INS、PTPN22、PPIL2、PLEKHA1、RNASET2位点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Prognostic factors and characteristics of children diagnosed with type 1 diabetes before 6 years of age were compared with those diagnosed at 6-13 years of age in the TEDDY study. METHODS: Genetically high-risk children (n = 8502) were followed from birth for a median of 9.9 years; 328 (3.9%) were diagnosed with type 1 diabetes. Cox proportional hazard model was used to assess the association of prognostic factors with the risk of type 1 diabetes in the two age groups. RESULTS: Children in the younger group tended to develop autoantibodies earlier than those in the older group did (mean age 1.5 vs 3.5 years), especially insulin autoantibodies (IAA), which developed earlier than GAD autoantibodies (GADA). Children in the younger group also progressed to diabetes more rapidly than the children in the older group did (mean duration 1.9 vs 5.4 years). Children with autoantibodies first appearing against insulinoma antigen-2 (IA-2A) were found only in the older group. The significant diabetes risk associated with the country of origin in the younger group was no longer significant in the older group. Conversely, the diabetes risk associated with HLA genotypes was statistically significant also in the older group. Initial seroconversion after and before 2 years of age was associated with decreased risk for diabetes diagnosis in children positive for multiple autoantibodies, but the diabetes risk did not decrease further with increasing age if initial seroconversion occurred after age 2. Diabetes risk associated with the minor alleles of rs1004446 (INS) was decreased in both the younger and older groups compared with other genotypes (HR 0.67). Diabetes risk was significantly increased with the minor alleles of rs2476601 (PTPN22) (HR 2.04 and 1.72), rs428595 (PPIL2) (HR 2.13 and 2.10), rs113306148 (PLEKHA1) (HR 2.34 and 2.21) and rs73043122 (RNASET2) (HR 2.31 and 2.54) (HR values represent the younger and older groups, respectively). CONCLUSIONS/INTERPRETATIONS: Diabetes at an early age is likely to be preceded by IAA autoantibodies and is a more aggressive form of the disease. Among older children, once multiple autoantibodies have been observed there does not seem to be any association between progression to diabetes and the age of the child or family history. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT00279318.
引用
- Krischer JP, Liu X, Lernmark Å, et al. Characteristics of children diagnosed with type 1 diabetes before vs after 6 years of age in the TEDDY cohort study. Diabetologia. 2021. PMID: 34291312. doi:10.1007/s00125-021-05514-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。